• Publications
  • Influence
Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications
Objective: Irrational use of antimicrobials is a major driver of antimicrobial resistance, exacerbated by dispensing antibiotics without a prescription. Our previous study suggested this was aExpand
  • 34
  • 5
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiatives across Europe to lower generic prices and enhance their utilization. However, considerableExpand
  • 110
  • 2
  • PDF
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications
BackgroundManaged entry agreements (MEAs) are a set of instruments to facilitate access to new medicines. This study surveyed the implementation of MEAs in Central and Eastern Europe (CEE) whereExpand
  • 58
  • 2
  • PDF
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries
Drug shortages have been identified as a public health problem in an increasing number of countries. This can negatively impact on the quality and efficiency of patient care, as well as contribute toExpand
  • 36
  • 2
  • PDF
Proposal for a regulation on health technology assessment in Europe – opinions of policy makers, payers and academics from the field of HTA
ABSTRACT Introduction: In January 2018 the European Commission published a Proposal for a Regulation on Health Technology Assessment (HTA): ‘Proposal for a Regulation on health technology assessmentExpand
  • 13
  • 2
Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
Introduction: There are increasing concerns world-wide with growing rates of antibiotic resistance necessitating urgent action. There have been a number of initiatives in the Republic of Srpska inExpand
  • 16
  • 2
Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs
Background: There are potential conflicts between authorities and companies to fund new premium priced drugs especially where there are safety and/or budget concerns. Dabigatran, a new oralExpand
  • 80
  • 1
  • PDF
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation
Medicines receiving a conditional marketing authorization through Medicines Adaptive Pathways to Patients (MAPPs) will be a challenge for payers. The “introduction” of MAPPs is already seen by theExpand
  • 31
  • 1
  • PDF
Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia & Herzegovina
PurposeThe aim of this study was to analyse the utilization patterns of drugs acting on the nervous system in the Republic of Srpska, Bosnia & Herzegovina between 2002 and 2008.MethodsThis was aExpand
  • 13
  • 1
Utilisation of cardiovascular medicines in Republic of Srpska, Bosnia and Herzegovina, 5 years study
The objective of this study was to analyse cardiovascular medicines utilisation patterns in Republic of Srpska (Bosnia and Herzegovina) over the 2002–2006 period.
  • 12
  • 1
...
1
2
3
4
...